Stem Cell Banking Market, by Source Type (Cord Blood and Cord Tissue), by Service Type (Collection and Transportation, Processing, Analysis and Storage), by Application (Leukemia, Diabetes, Lymphoma, Cerebral Palsy, Thalassemia and Others), and by Region - Global Trends, and Forecast to 2025
- Report code : CMI11354 |
- Industry :
Biotechnology
- Published On : Feb 2018 |
- Pages : 148 Pages |
- Format :
Stem Cell Banking Market – Assurance for a Lifetime
Stem cells are building blocks of the immune system and blood, and they have the ability to develop into other cell types, in order to help in repairing tissues, organs, blood vessels, and are used in treatment of various disease. The ability of stem cells to regenerate has led to development of various treatments with it, to cure various genetic and auto-immune diseases and disorders. Cord blood stem cells have been used to treat nearly 80 diseases, including numerous types of malignancies, anemia, inherited metabolic disorders, and deficiencies of the immune system. Moreover, with the advancement in regenerative medicine, individuals of all ages can benefit from stem cell therapy in the near future. This is expected to augment growth of the market. Stem cell banking market is expected to gain significant traction, owing to factors such as rising awareness about the therapeutic importance of stem cells, growing number of clinical trials for products that are stem cell-based, and increasing research grants and public-private funding for development of novel treatments that are stem cell-based.
The global stem cell banking market was valued at US$ 1,634.7 million in 2016 and is expected to exhibit a robust CAGR of 18.9% over the forecast period (2017–2025).
Figure 1. Global Stem Cell Banking Market Value (US$ Mn), by Region, 2016
Source: Coherent Market Insights (2018)
High therapeutic potential of stem cells for treating genetic diseases is expected to aid in growth of the market
High potential of cord blood and tissues for the treatment of patients with autoimmune diseases is expected to propel the market growth. Moreover, currently available immunosuppressive agents such as steroids, induce long term side effects despite temporary improvements. According to the Health Research Funding, 2015, around 28% of cord blood transplants have been used to treat genetic diseases, with the most common genetic disease treated being severe combined immune deficiency, followed by aplastic anemia. According to the National Cord Blood Program, 2015, cord blood from unrelated donors has been used as an alternative to bone marrow or mobilized stem cells, as a source of hematopoietic stem cells, with over 35,000 stem cell transplants successfully performed worldwide.
Stem cells can be stored indefinitely and can easily retain viability even after a decade of storage and this is a major factor driving growth of the market. A study of cord blood stem cells conducted at Indiana University in 2016 demonstrated its viability after 23.5 years of cryogenic storage. Moreover, increasing awareness about stem cell preservation and significance in treating life-threatening diseases has led to increasing demand for of stem cell collection and preservation techniques, thus bolstering the market growth.
Asia Pacific is expected to exhibit significant growth in the global stem cells banking market over the forecast period. This is owing to rising birth rates coupled with increasing prevalence of birth defects, and options of paying for stem banking in monthly instalments, making it accessible to a number of people. For instance, according to the survey by Save the Children India, 2012, India has a booming birth rate of 26 million per year and this is aiding in growth of the market. According to Multicenter Study, 2013, about 10,000 to 15,000 infants are diagnosed suffering from thalassemia and sickle cell anemia in India, indicating high demand for stem cells banking.
However, high cost of stem cell banking is a major hindrance for growth of the market. Stem cell preservation services are expensive and everyone cannot afford it. For instance, according to Meredith Corporation, a private bank generally charges US$ 1,000 to US$ 2,000 to collect cord blood at the time of delivery, with annual storage fees of US$ 100 to US$ 300 each year.
Supportive stem cell research initiatives for personalized medicine to accelerate the market growth
Stem cell banking offers the advantage that it can be readily used, whenever the need for arises, and does not need to be closely matched as bone marrow. According to the Health Research Funding Organization, 2015, children, who received matched cord blood had a 20% higher survival rate than those children who received matched bone marrow. Government organizations are offering support to conduct research and clinical trials for cord blood stem cell. Therefore, healthcare companies are increasing focusing on investing in research and commercialization of cord blood stem cell therapies thus, augmenting growth of stem cell banking market in the near future. For instance, the International Stem Cell Forum (ISCF) was launched to encourage international collaboration and provide funding for stem cell research. The aim of ISCF was to promote global good practice and accelerate progress in the area of stem cell research. Moreover, the UK Stem Cell Bank (UKSCB) provides an international resource for stem cell research by supplying human stem cell lines for the purpose of research and development of stem cell lines for clinical purpose. It also has an active program for research in collaboration with academic institutions.
Major players operating in the global stem cell banking market are Allergan, Plc., Galderma S.A., Integra LifeSciences Corporation, Merz Pharma GmbH & Co. KGaA., Sanofi S.A., SciVision Biotech Inc., Sinclair Pharma Plc., Suneva Medical, Valeant Pharmaceuticals International, Inc., and Anika Therapeutics, Inc.
Stem cells have the potential to transform to any tissue or organ in the body. Stem cells can be found in bone marrow, fetal tissues, baby teeth, fat, human embryos, hair follicles, muscle, and circulating blood, however, cord blood is an effective source of stem cells. Stem cells from cord blood are preferred due to various advantages such as efficacy in transplant due to less chances of immune rejection during the transfusion. Numerous applications of stem cells such as treatment in various diseases such as cancer, have led to demand for stem cell banking. These stem cells are collected from humans and preserved for the future use.
Market Dynamics
Increasing incidences of chronic disease and the effectiveness of stem cell therapy in the treatment of such diseases is a major driving factor for growth of stem cell banking market. According to the survey by Seattle Children’s Hospital and Research Center, 2013, the survival rate of patient with cancer after stem cell transplant for period of one year was 84% globally. Growing public awareness for stem cell storage is also contributing to stem cell banking market growth. Additionally, new clinical trial data that supports applications for hematopoietic stem cells from mesenchymal stem cells and cord blood is expected to help in growth of stem cell banking market. Moreover, various organizations are supporting stem cell banking, which is expected to aid in growth of the market. For instance, in 2012, Harvard University and University of Cambridge announced plans to set up a new stem cells research center, funded by Medical Trust UK and UK Medical Research Council, to conduct research on stem cells and their potential to treat a range of life-threatening conditions. However, low availability of cord blood units, globally and high cost for maintenance are hindering growth of the stem cell banking market.
Key features of the study:
- This report provides in-depth analysis of stem cell banking market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global stem cell banking market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans
- Key companies covered as a part of this study include Stem Cyte, Inc., Cryo-cell International, ViaCord, Cord Blood Registry, SmartCells, Inc., LifeCell International Pvt. Ltd., Cryoviva Biotech Pvt. Ltd., Cryo Stemcell, Reliance Life Sciences, and Transcell Biolife Pvt. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global stem cell banking market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the stem cell banking market
Detailed Segmentation:
- Global Stem Cell Banking Market, By Source Type:
- Cord Blood
- Cord Tissue
- Global Stem Cell Banking Market, By Service Type:
- Collection and Transportation
- Processing
- Analysis
- Storage
- Global Stem Cell Banking Market, By Application:
- Leukemia
- Diabetes
- Lymphoma
- Cerebral Palsy
- Thalassemia
- Others
- Global Stem Cell Banking Market, By Geography:
- North America
- By Source Type:
- Cord Blood
- Cord Tissue
- By Service Type:
- Collection and Transportation
- Processing
- Analysis
- Storage
- By Application:
- Leukemia
- Diabetes
- Lymphoma
- Cerebral Palsy
- Thalassemia
- Others
- By Country:
- U.S.
- Canada
- Latin America
- By Source Type:
- Cord Blood
- Cord Tissue
- By Service Type:
- Collection and Transportation
- Processing
- Analysis
- Storage
- By Application:
- Leukemia
- Diabetes
- Lymphoma
- Cerebral Palsy
- Thalassemia
- Others
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Source Type:
- Cord Blood
- Cord Tissue
- By Service Type:
- Collection and Transportation
- Processing
- Analysis
- Storage
- By Application:
- Leukemia
- Diabetes
- Lymphoma
- Cerebral Palsy
- Thalassemia
- Others
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Source Type:
- Cord Blood
- Cord Tissue
- By Service Type:
- Collection and Transportation
- Processing
- Analysis
- Storage
- By Application:
- Leukemia
- Diabetes
- Lymphoma
- Cerebral Palsy
- Thalassemia
- Others
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Source Type:
- Cord Blood
- Cord Tissue
- By Service Type:
- Collection and Transportation
- Processing
- Analysis
- Storage
- By Application:
- Leukemia
- Diabetes
- Lymphoma
- Cerebral Palsy
- Thalassemia
- Others
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Source Type:
- Cord Blood
- Cord Tissue
- By Service Type:
- Collection and Transportation
- Processing
- Analysis
- Storage
- By Application:
- Leukemia
- Diabetes
- Lymphoma
- Cerebral Palsy
- Thalassemia
- Others
- By Country:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Stem Cyte, Inc. *
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Cryo-cell International
- ViaCord
- Cord Blood Registry
- SmartCells, Inc.
- LifeCell International Pvt. Ltd.
- Cryoviva Biotech Pvt. Ltd.
- Cryo Stemcell
- Reliance Life Sciences
- Transcell Biolife Pvt. Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Source Type
- Market Snippet, By Service Type
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Technological Advancements
- Regulatory Scenario
- Reimbursement Scenario
- PEST Analysis
- Porter’s Analysis
- Epidemiology
- Global Stem Cell Banking Market, By Source Type, 2015–2025, (US$ Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Cord Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Cord Tissue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Global Stem Cell Banking Market, By Service Type, 2015–2025, (US$ Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Collection and Transportation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Storage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Global Stem Cell Banking Market, By Application, 2015–2025, (US$ Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Lymphoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Cerebral Palsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Thalassemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
- Global Stem Cell Banking Market, By Region, 2015–2025, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, For Regions, 2016–2025
- North America
- Market Size and Forecast, By Source Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Service Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Application, 2015–2025, (US$ Million)
- Market Size and Forecast, By Country, 2015–2025, (US$ Million)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Source Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Service Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Application, 2015–2025, (US$ Million)
- Market Size and Forecast, By Country, 2015–2025, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Source Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Service Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Application, 2015–2025, (US$ Million)
- Market Size and Forecast, By Country, 2015–2025, (US$ Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Source Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Service Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Application, 2015–2025, (US$ Million)
- Market Size and Forecast, By Country, 2015–2025, (US$ Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Source Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Service Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Application, 2015–2025, (US$ Million)
- Market Size and Forecast, By Country, 2015–2025, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Source Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Service Type, 2015–2025, (US$ Million)
- Market Size and Forecast, By Application, 2015–2025, (US$ Million)
- Market Size and Forecast, By Country, 2015–2025, (US$ Million)
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profiles
- Stem Cyte, Inc.
- Company Overview
- Product Portfolio
- Financials
- Key Developments
- Strategies
- Cryo-cell International
- Company Overview
- Product Portfolio
- Financials
- Key Developments
- Strategies
- ViaCord
- Company Overview
- Product Portfolio
- Financials
- Key Developments
- Strategies
- Cord Blood Registry
- Company Overview
- Product Portfolio
- Financials
- Key Developments
- Strategies
- SmartCells, Inc.
- Company Overview
- Product Portfolio
- Financials
- Key Developments
- Strategies
- LifeCell International Pvt. Ltd.
- Company Overview
- Product Portfolio
- Financials
- Key Developments
- Strategies
- Cryoviva Biotech Pvt. Ltd.
- Company Overview
- Product Portfolio
- Financials
- Key Developments
- Strategies
- Cryo Stemcell
- Company Overview
- Product Portfolio
- Financials
- Key Developments
- Strategies
- Reliance Life Sciences
- Company Overview
- Product Portfolio
- Financials
- Key Developments
- Strategies
- Transcell Biolife Pvt. Ltd.
- Company Overview
- Product Portfolio
- Financials
- Key Developments
- Strategies
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 36 market data tables and 24 figures on "Stem Cell Banking Market - Global forecast to 2025”.
Research Methodology
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
- Primary Research (Trade Surveys and Experts Interviews)
- Desk Research
- Proprietor Data Analytics Model
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
- National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
- Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
- Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
- Trade association, National and international media and trade press.
- Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
- Scientific journals, and other technical magazines and whitepapers.
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Data Standardization:
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
- Micro-economic indicators
- Macro-economic indicators
- Environmental indicators
- Socio-political indicators
- Technology indicators
Data Processing
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
Data Validation
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
- It provides first-hand information on the market dynamics, outlook, and growth parameters.
- Industry experts validates the estimates which helps the company to cement the on-going research study.
- Primary research includes online surveys, face-to face interviews, and telephonic interviews.
The primary research is conducted with the ecosystem players including, but not limited to:
- Raw Material Suppliers
- Manufacturers
- System Integrators
- Distributors
- End-users
Related Insights :
Share
Choose License Type
"How Can I Help You" ?
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Key Benefits
Custom Research Solution
Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment
We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality
We strive to provide most accurate and reliable research findings in our research reports.